Skip to content

A study of structured group therapy combined with medication for adolescent depression rehabilitation and prevention of relapse

A study of structured group therapy combined with medication for adolescent deprdssion rehabilitation and prevention of relapse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119236
Enrollment
Unknown
Registered
2026-02-24
Start date
2023-03-10
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent depression

Interventions

Control Group :Take the medicine approved by the National Food and Drug Administration for the treatment of depression. The dosage can be appropriately adjusted every week. The maximum dosage is the m
Experimental group:After randomization, relevant scale assessments were given before, during and after treatment. The observation group was treated with a structured group therapy programme in conjunc
members randomly divided into the observation group were divided into 5 groups, each group consisted of 10 people to form a group, and a total of 5 groups were formed in the order of time, and the tea

Sponsors

Chuanshou City Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. For patients who were hospitalized in the Children and Adolescents Department of Chuzhou Second People's Hospital from May 2022 to December 2024; 2. Age between 12 and 18 years old; 3. After the three-level ward rounds, the diagnosis met the diagnostic criteria of the International Classification of Diseases, Tenth Revision (ICD-10); 4. The patients cooperated well, their depressive symptoms were relieved, the condition was relatively stable, they had certain communication skills, their social functions were slightly impaired, their self-awareness was intact; the total score of HAMD-17 was 7 points; the disease course was >2 weeks; 5. Normal intelligence

Exclusion criteria

Exclusion criteria: 1. Comorbid with severe diseases of important organs such as the heart, liver, and kidneys; 2. Has a history of severe brain organic lesions and substance addiction; 3. Has other severe mental disorders; 4. Had individual psychological therapy within 3 months before treatment; 5. Has a serious tendency or behavior of suicide; 6. The patient and his/her family are resistant to treatment, or absent or withdraw without reason during the treatment period.

Design outcomes

Primary

MeasureTime frame
Depressive condition;

Secondary

MeasureTime frame
Anxiety condition;Reduction rate;

Countries

China

Contacts

Public ContactBin Wang

Chuanshou City Second People's Hospital

singhighy@163.com+86 550 352 3663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026